Pharmaceuticals

Cancer Immunotherapy Market Size and Growth Forecast for Businesses 2025–2029

November 7, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Cancer Immunotherapy Market Size During 2025–2029?

The cancer immunotherapy market has witnessed significant expansion in recent years. It is projected to grow from $110.91 billion in 2024 to $124.09 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.9%. This historical growth can be attributed to factors such as the increasing prevalence of cancer, the heightened adoption of immunotherapy over traditional therapies, expanding research and development initiatives for the creation of targeted treatments, the improved effectiveness and precision of newer therapies, and a rising awareness of the limitations of conventional cancer treatments.

The cancer immunotherapy market size is anticipated to experience significant expansion in the foreseeable future, projected to reach $189.5 billion by 2029, growing at a compound annual growth rate (CAGR) of 11.2%. This growth over the forecast period is fueled by several factors: the increasing approval of innovative immunotherapies for cancer treatment, the escalating demand for personalized medicine, a rise in cancer detection rates, increased investment in clinical trials to develop advanced treatments, and greater awareness surrounding cancer immunotherapy. Noteworthy trends during this period encompass the emergence of adoptive cell therapies, including CAR-T cells, the exploration of oncolytic viruses in cancer immunotherapy, the development of individualized cancer vaccines, the application of artificial intelligence in immunotherapy research, and a heightened focus on real-world evidence and patient outcomes in guiding treatment decisions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6768&type=smp

What Are The Top Growth Drivers Impacting The Cancer Immunotherapy Market Outlook?

The growing incidence of cancer is anticipated to propel the cancer immunotherapy market. The expansion in cancer diagnoses worldwide stems from factors like tobacco use, alcohol consumption, obesity, sedentary lifestyles, and environmental influences. This rise in cancer cases is expected to elevate the demand for cancer immunotherapies, as patients are increasingly choosing medical treatments that offer better recovery prospects and less discomfort. For instance, in October 2023, the European Union Science Hub, a Belgium-based European Commission’s Joint Research Centre, reported that new cancer cases had grown by 2.3% over the preceding two years, reaching 2.74 million in 2022. Similarly, cancer fatalities climbed by 2.4% during the same two-year timeframe. Therefore, the increase in cancer incidence is projected to boost the demand for cancer immunotherapy throughout the forecast period.

What Are The Emerging Segments Gaining Attention In The Cancer Immunotherapy Market?

The cancer immunotherapy market covered in this report is segmented –

1) By Product: Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy

2) By Application: Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Multiple Myeloma

3) By End User: Hospitals, Cancer Research Centers, Clinics

Subsegments:

1) By Monoclonal Antibodies: Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, Fully Human Monoclonal Antibodies

2) By Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors

3) By Immunomodulators: Cytokines, Oncolytic Viruses, Toll-Like Receptor (TLR) Agonists

4) By Vaccines: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines

5) By Cell Therapy: CAR T-Cell Therapy, TCR Therapy, Natural Killer (NK) Cell Therapy

What Are The Latest Industry Trends Transforming The Cancer Immunotherapy Market?

The increasing use of advanced technologies in cancer immunotherapy represents a key trend gaining traction within the market. There’s been a significant growth in new technologies and various treatments aimed at assisting the immune system in identifying and targeting tumors, utilizing approaches such as immuno-oncology, cryoablation, bone marrow transplant, and radiation therapy. These innovations can substantially impact cancer treatment and potential cures. For example, in October 2022, AstraZeneca plc, a UK-based pharmaceutical and biotechnology company, announced the approval of its drug Capivasertib when combined with Faslodex. This cancer immunotherapeutic is designed for breast cancer treatment and has proven effective following recurrence or progression after endocrine therapy in locally advanced or metastatic breast cancer with low or negative human epidermal growth factor receptor 2 (HER2).

Who Are The Prominent Global Companies Shaping The Cancer Immunotherapy Market?

Major companies operating in the cancer immunotherapy market include Amgen Inc., AstraZeneca PLC, F. Hoffmann-La Roche Ltd, Bayer AG, Eli Lilly and Company, 3D Signatures Inc., Adaptive Biotechnologies Corp., Argos Therapeutics Inc., Bristol-Myers Squibb Company, Cell Medica Limited, Cellular Biomedicine Group Inc., Gilead Sciences Inc., Gradalis Inc., Immatics Biotechnologies GmbH, Iovance Biotherapeutics Inc., Juno Therapeutics LLC, Kura Oncology Inc., MacroGenics Inc., Merck & Co. Inc., Neon Therapeutics Inc., Neovii Biotech GmbH, Novartis International AG, Pfizer Inc., Pulse Biosciences Inc., Regeneron Pharmaceuticals Inc., Roche Holding AG, Targovax ASA, Tessa Therapeutics Pte Ltd., TILT Biotherapeutics Ltd., Turnstone Biologics Corp., Xencor Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cancer-immunotherapy-global-market-report

Which Region Currently Holds The Largest Share Of The Cancer Immunotherapy Market?

North America was the largest region in the cancer immunotherapy market in 2024 and is also expected to be the fastest-growing region in the forecast period. The regions covered in the cancer immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Cancer Immunotherapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=6768&type=smp

Browse Through More Reports Similar to the Global Cancer Immunotherapy Market 2025, By The Business Research Company

Pain Management Devices And Therapies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report

Metabolomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Isothermal Nucleic Acid Amplification Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795